Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection
Hepatology2008Vol. 47(6), pp. 1837–1845
Citations Over TimeTop 1% of 2008 papers
Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilâ, Mads Rauning Buhl, Kristine Mφrch, Amar P. Dhillon, Åsa Alsiö, Kristoffer Hellstrand, Johan Westin, Gunnar Norkrans
Abstract
Peginterferon/ribavirin treatment for 12 weeks in HCV genotype 2/3 infection is overall inferior to 24 weeks of treatment but may be useful in some patients with a rapid initial clearance of virus.
Related Papers
- Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients -(2005)
- → Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production(2015)8 cited
- → Ribavirin with or without alpha interferon for chronic hepatitis C(2002)19 cited
- → Alpha-interferon with ribavirin for the treatment of chronic hepatitis C in treatment naive patients(2000)2 cited
- → IFN alfa-con 1 + ribavirin combination therapy in naive difficult-to-treat patients affected by chronic hepatitis C(2001)